Skip to main content

Advertisement

Log in

Inhibition of Matrix Metalloproteinase-1 by Dichloromethylene Bisphosphonate (Clodronate)

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract.

Interstitial collagenase present in human jaw cyst extract and purified human fibroblast-type collagenase (MMP-1) were both efficiently inhibited in vitro by clodronate, an osteoactive, antiresorptive bisphosphonate. The IC50 of clodronate to inhibit MMP-1 is 150 μM. These findings suggest an extended and hitherto undescribed properties for clodronate/biphosphonates in prevention and treatment of tissue degradation in both bone and soft tissue destructive diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 15 July 1996/Accepted: 10 December 1996

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teronen, O., Konttinen, Y., Lindqvist, C. et al. Inhibition of Matrix Metalloproteinase-1 by Dichloromethylene Bisphosphonate (Clodronate). Calcif Tissue Int 61, 59–61 (1997). https://doi.org/10.1007/s002239900295

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002239900295

Navigation